Lumbers, RT;
Martin, N;
Manoharan, K;
Nyong, J;
Thomas, J;
Casas, JP;
Davies, C;
(2017)
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
Cochrane Database of Systematic Reviews
, 2017
(7)
, Article CD012721. 10.1002/14651858.CD012721.
Preview |
Text
Lumbers_et_al-2017-.pdf - Published Version Download (182kB) | Preview |
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the safety and efficacy of beta-blockers (BBs), angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor antagonists (ARBs), mineralocorticoid receptor antagonists (MRAs), and angiotensin receptor neprilysin inhibitors (ARNIs) for the treatment of patients with heart failure (HF) with preserved ejection fraction (HFpEF).
Archive Staff Only
View Item |